Compare CVS Health Corp (CVS) vs Gigacloud Technology Inc (GCT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Gigacloud Technology Inc — how do they compare? CVS Health Corp trades at $86.43 (market cap $112.49B), while Gigacloud Technology Inc trades at $56.59 (market cap $2.00B). The key difference: CVS Health Corp is far larger — about 56.2× Gigacloud Technology Inc's market cap, and CVS Health Corp pays a 3.02% dividend while Gigacloud Technology Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Gigacloud Technology Inc for 21 Days on average.
| CVS | GCT | |
|---|---|---|
Market Cap | $112.49B | $2.00B |
Volume | 8,467,392 | 1,000,927 |
Sector | Health | Technology |
52-Week High | $110.60 | $56.42 |
52-Week Low | $70.08 | $25.46 |
Typical Hold Time | 83 Days | 21 Days |
Enterprise Value | $174.83B | $2.13B |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
GCT trades at $55.96, up 2.19% today, with a bullish technical signal from moving averages and strong fundamental performance. The company reported Q2 2026 EPS of $1.16, beating estimates of $0.90, continuing a trend of earnings beats. Revenue grew to $1.29 billion in 2025, with net income of $137.37 million and a healthy net margin of 10.65%. The stock is supported by positive cash flow from operations of $190.66 million in 2025.
The outlook for GCT is positive, driven by consistent earnings outperformance and robust profitability metrics like a 32.34% ROE. Risks include potential overbought conditions with an RSI of 72.38 and insider selling activity. Analyst consensus is bullish with a $32.50 price target, though the current price exceeds this, suggesting cautious optimism amid growth execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Gigacloud Technology Inc
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →
